Product Catalog
Blends
Protocols
Explore Our Products
All orders ship same day from our US facility.
Made in the USA
Peptides are precision-synthesized and lyophilized at state-of-the-art laboratories in the United States.
Frequently Asked Questions
Peptides are short chains of amino acids that occur naturally in organisms, where they act as messengers in many biological systems. While some peptides have been developed for medical use, laboratory research focuses on understanding their activity at the cellular level, examining how they impact essential processes in vitro.
Products from Direct Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
Orders are typically processed and shipped within 24 hours on weekdays. Delivery times vary by location, but most domestic orders arrive within 3β5 business days. Youβll receive tracking information as soon as your order ships.
BPC-157 + TB-500
What Is the BPC-157 & TB-500 Blend?
The BPC-157 + TB-500 blend is a peptide combination frequently examined in laboratory and preclinical research focused on tissue response, cellular repair mechanisms, and angiogenic signaling.
BPC-157 is a synthetic peptide derived from a naturally occurring gastric protein fragment.
TB-500 is a synthetic peptide modeled after thymosin beta-4 (TΞ²4), a protein involved in actin regulation and cellular migration.
Together, this blend is commonly studied in vitro and in animal models for its relevance to cytoskeletal dynamics, vascular signaling, and regenerative biology.
Certificate of Analysis
Third-party tested for 99% purity
BPC-157 + TB-500 Overview
The BPC-157 + TB-500 blend combines two synthetic peptides that are extensively studied for their roles in regenerative and repair-related biological processes.
BPC-157 is associated in research with cellular protection, collagen regulation, inflammatory pathway modulation, and gastrointestinal resilience.
TB-500, a synthetic fragment of thymosin beta-4, is studied for its involvement in cell migration, angiogenesis, actin remodeling, and tissue flexibility.
When examined together, these peptides are often evaluated for complementary activity in models related to recovery, repair, and connective tissue support.
Goldstein AL et al., 2005History and Development
The rationale behind combining BPC-157 and TB-500 arises from parallel discoveries in regenerative biology.
BPC-157 was synthesized following investigations into cytoprotective peptides found in gastric juice, with early research emphasizing gastrointestinal integrity before expanding into musculoskeletal, vascular, and dermal systems.
Thymosin beta-4 (TΞ²4) was first identified in the 1960s by Allan L. Goldstein and colleagues during studies on thymic peptides. Subsequent research revealed its role in wound healing, angiogenesis, and cytoskeletal organization. TB-500, a synthetic peptide derived from TΞ²4, emerged as a research tool to study these mechanisms more directly.
Together, these peptides became of interest for laboratory research into tissue regeneration, vascular remodeling, and systemic protection.
Goldstein AL, Hannappel E. et al., 2012BPC-157 Structure
TB-500 Structure
Research Findings
BPC-157 and TB-500 have been studied across structural, vascular, dermatological, and systemic research models.
Key Areas of Investigation
- Structural: Tendon-to-bone healing, collagen organization, connective tissue repair
- Vascular: Angiogenesis, nitric oxide signaling, vascular remodeling
- Dermatological: Wound closure dynamics, epithelial regeneration, inflammation modulation
- Systemic: Gastrointestinal integrity, cellular survival, recovery signaling
Collectively, these findings suggest broad experimental applications for the BPC-157 + TB-500 blend. Their combined influence on collagen synthesis, vascular pathways, inflammatory modulation, and systemic protection provides a versatile foundation for research into tissue repair, recovery processes, and regenerative biology in controlled laboratory environments.
Sikiric P. et al., 2018
